《LANCET,2月19日,Enteric involvement of coronaviruses: is faecal–oral transmission of SARS-CoV-2 possible?》

  • 来源专题:COVID-19科研动态监测
  • 编译者: zhangmin
  • 发布时间:2020-02-20
  • Enteric involvement of coronaviruses: is faecal–oral transmission of SARS-CoV-2 possible?

    Charleen Yeo, Sanghvi Kaushal, Danson Yeo

    Published:February 19, 2020DOI:https://doi.org/10.1016/S2468-1253(20)30048-0

    The end of 2019 was marked by the emergence of a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which caused an outbreak of viral pneumonia (COVID-19) in Wuhan, China. At the time of writing, SARS-CoV-2, previously known as 2019-nCoV, has spread to more than 26 countries around the world. According to the WHO COVID-19 situation report-28 released on Feb 17, 2020, more than 71?000 cases have been confirmed and at least 1770 deaths.

  • 原文来源:https://www.thelancet.com/journals/langas/article/PIIS2468-1253(20)30048-0/fulltext
相关报告
  • 《Nature,3月25日,COVID-19: faecal–oral transmission?》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-03-26
    • COVID-19: faecal–oral transmission? Jordan Hindson Nature Reviews Gastroenterology & Hepatology (2020) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, which causes coronavirus disease 2019 (COVID-19), first emerged in China in December 2019 and has now spread worldwide, with a reported 351,731 confirmed cases and 15,374 deaths as of 23 March 2020 according to John Hopkins University. The infection is typically characterized by respiratory symptoms, which indicates droplet transmission. However, several case studies have reported gastrointestinal symptoms and/or evidence that some patients with SARS-CoV-2 infection have viral RNA or live infectious virus present in faeces, which suggests that another possible route might be faecal–oral transmission.
  • 《LANCET,3月23日,SARS-CoV-2: virus dynamics and host response》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-03-24
    • SARS-CoV-2: virus dynamics and host response Yu Chen Lanjuan Li Published:March 23, 2020DOI:https://doi.org/10.1016/S1473-3099(20)30235-8 Since December, 2019, coronavirus disease 2019 (COVID-19) has affected more than 100?000 patients globally.1 COVID-19 is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and has a case-fatality rate of 2·3%, with higher rates among elderly patients and patients with comorbidities.2 Person-to-person transmission is efficient, with multiple clusters reported. Clinically, patients with COVID-19 present with respiratory symptoms, which is very similar to the presentation of other respiratory virus infections.